Yixintang Pharmaceutical Group Co., Ltd. announced that it will raise a round of funding on June 1, 2023. The company will issue convertible corporate bonds in the transaction. The transaction has been approved by the shareholder of the company in 1st extraordinary general meeting of 2023.